Relationship between thiolactonase activity and hyperhomocysteinemia according to MTHFR gene polymorphism in Tunisian Behçet's disease patients
Authors:
- Nadia KoubaaNKNadia Koubaa
- Sonia HammamiSHSonia Hammami
- Amel NakbiANAmel Nakbi
- Khaldoun Ben HamdaKHKhaldoun Ben Hamda
- Sylvia MahjoubSMSylvia Mahjoub
- Testsuya KosakaTKTestsuya Kosaka
- Mohamed HammamiMHMohamed Hammami
- 1 January 2008
- journal article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 46 (2) , 187-92
Abstract
Behçet's disease (BD) is a multisystemic immuno-inflammatory disorder. Inflammatory processes may cause lipid peroxidation, alteration of lipid profile and increase the risk of atherosclerosis. The aim of this study was to evaluate the association between thiolactonase (HTLase) activity and plasma homocysteine levels (tHcy) in a BD population and to investigate their association with methylenetetrahydrofolate reductase (MTHFR) 677C-->T genotype. A total of 35 BD patients were compared to 39 healthy volunteers. Significantly higher tHcy levels associated with lower HTLase activities were found in BD patients as compared to healthy controls (p<0.001). These patients also exhibited lower values of triglycerides and high-density lipoprotein cholesterol (HDL-C). Homozygosity for the T allele of the MTHFR gene was more frequent in BD patients (14.3% vs. 7.7%). It was associated with significantly higher tHcy levels (16.9 micromol/L for n=17 vs. 13.1 micromol/L for n=18; p<0.05) and markedly lower HTLase activity (362.6+/-156.7 U/L vs. 414.2+/-180.2 U/L) for the (TT+CT) and CC genotypes, respectively. Moreover, HDL-C levels were inversely correlated with tHcy (r=-0.5; p=0.004) but positively associated with HTLase activity (r=0.374; p=0.038). These correlations were also present in several clinical manifestations, such as ocular, neurological involvement or thrombosis. Homozygosity of the T allele of the MTHFR gene is prevalent in BD patients. High levels of tHcy associated with low HTLase activities may be one of the causes leading to thrombosis in BD patients.Keywords
This publication has 27 references indexed in Scilit:
- Behçet’s diseaseMedicine, 2006
- Investigation of the relationship between atherosclerosis and paraoxonase or homocysteine thiolactonase activity in patients with type 2 diabetes mellitus using a commercially available assayClinica Chimica Acta, 2005
- Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Beh et's diseaseRheumatology International, 2003
- Evaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?Annals of Internal Medicine, 1999
- Hyperhomocysteinemia and Atherosclerotic Vascular DiseaseArchives of internal medicine (1960), 1998
- Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes MellitusArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Hyperhomocysteinemia in Retinal Artery and Retinal Vein OcclusionAmerican Journal of Ophthalmology, 1993
- Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis.Journal of Clinical Investigation, 1976